A Phase I/II Double-Blind, Randomized Study of the Safety, Tolerability and Systemic Absorption of TMC120 [dapivirine] Vaginal Microbicide Gel and Matching Placebo in Healthy HIV-Negative Women.
Phase of Trial: Phase I/II
Latest Information Update: 31 Jul 2009
At a glance
- Drugs Dapivirine (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors International Partnership for Microbicides
- 31 Jul 2009 Results have been reported in AIDS.
- 14 Oct 2006 New trial record.